UI to offer free vaccine clinics in an effort to prevent spread of of measles, mumps and rubella

Photo by Stephen Cummings
Photo by Stephen Cummings

The University of Iowa will host a series of vaccine clinics across campus this week, offering students under the age of 25 a chance to receive a third dose of the measles, mumps and rubella (MMR) vaccine free of charge.

Officials will conduct the clinics in an effort to prevent the spread of infection among students and Iowans at large. Dr. Kathleen Wittich, medical director of UI Student Health and Wellness, notes that the Iowa City community has seen at least 100 cases of mumps over the last few months, with infection rates increasing “in recent weeks.” Indeed, a report published last month by Little Village showed that Iowa saw 60 cases of mumps between July and October, with 50 of those cases appearing in Johnson County. Of these 50 county-wide cases, 40 involved students at the University of Iowa.

Most students receive a mumps vaccine prior to starting kindergarten. However, this immunity wanes over time and needs to be boosted in order to stay effective. Johnson County Public Health Director Doug Beardsley says getting a third dose of the MMR vaccine is a “proactive approach to curtail this illness.” In addition to fever and swollen glands, complications from mumps can lead to deafness and testicular swelling, both of which have occurred this year among UI students, according to Dr. Patricia Quinlisk, medical director at the Iowa Department of Public Health.

The UI’s free MMR vaccine clinics will operate from Tuesday, Nov. 10 through Tuesday, Nov. 17. Students must bring a student ID in order to receive the vaccine.

Nov. 10 Iowa Memorial Union Main Lounge 10 a.m. to 7 p.m.
Nov. 11 Iowa Memorial Union 2nd Floor Ballroom 10 a.m. to 7 p.m.
Nov. 16 Burge Hall 11 a.m. to 2 p.m.
Nov. 16 Mayflower Hall 4 p.m. to 9 p.m.
Nov. 17 Hillcrest Hall 4 p.m. to 9 p.m.



  1. First of all-the shots are not free. They are paid for with the American people’s tax dollars.
    Second: things you should know:
    Measles outbreaks over the last several years have been happening in highly vaccinated populations. Some as much as 99% as in China and Canada. The vaccine is spreading Measles. The strain of measles in California in 2014-5b was a vaccine strain which means it came from a vaccinated individual shedding the virus.
    -Arch Intern Med. 1994 Aug 22;154(16):1815-20.
    Failure to reach the goal of measles elimination. Apparent paradox of measles infections in immunized persons.
    Poland GA1, Jacobson RM.
    Conclusion: The apparent paradox is that as measles immunization rates rise to high levels in a population, measles becomes a disease of immunized persons. Because of the failure rate of the vaccine and the unique transmissibility of the measles virus, the currently available measles vaccine, used in a single-dose strategy, is unlikely to completely eliminate measles. The long-term success of a two-dose strategy to eliminate measles remains to be determined. http://archinte.jamanetwork (dot) com/article.aspx?articleid=619215
    “The measles vaccine has failed”, he explained two years ago in a prescient paper, “The re-emergence of measles in developed countries.” In that paper, he warned that due to factors that most haven’t noticed, measles has come back to be a serious public health threat. Poland sees the need for a major rethink, after concluding that the current measles vaccine is unlikely to ever live up to the job expected of it: “outbreaks are occurring even in highly developed countries where vaccine access, public health infrastructure, and health literacy are not significant issues. This is unexpected and a worrisome harbinger — measles outbreaks are occurring where they are least expected,” he wrote in his 2012 paper, listing the “surprising numbers of cases occurring in persons who previously received one or even two documented doses of measles-containing vaccine.” During the 1989-1991 U.S. outbreaks, 20% to 40% of those affected had received one to two doses. In a 2011 outbreak in Canada, “over 50% of the 98 individuals had received two doses of measles vaccine.”
    Paper: The Re-Emergence of Measles in Developed Countries: Time to Develop the Next-Generation Measles Vaccines? http://www.ncbi.nlm.nih (dot) gov/pmc/articles/PMC3905323/
    http://business.financialpost (dot) com/2014/05/01/lawrence-solomon-vaccines-cant-prevent-measles-outbreaks/.
    Dr. Gregory Poland is Professor of Medicine and founder and leader of Mayo Clinic’s Vaccine Research Group. Poland is one of the world’s most admired, most advanced thinkers in the field of vaccinology.

  2. Former Merck scientists file suit against Merck under False Claims Act: A formal complaint was filed in the Eastern Pennsylvania Federal District Court accusing Merck of a longstanding scheme to mislead and defraud Government health authorities worldwide. Two of Merck’s former employees have accused the pharmaceutical giant of marketing multivalent MMR vaccines under false pretenses. According to the complaint, these vaccines have been mislabeled, misbranded, adulterated and falsely certified as having a 95% efficacy rate.

    Court documents filed for the mumps component of their multivalent MMR vaccine.
    The suit alleges: alleges -[Merck engaged in] …a decade-long scheme to falsify and misrepresent the true efficacy of its vaccine.
    -Merck fraudulently represented and continues to falsely represent in its labeling and elsewhere that its Mumps Vaccine has an efficacy rate of 95 percent of higher.
    -In reality, Merck knows and has taken affirmative steps to conceal — by using improper testing techniques and falsifying test data — that its Mumps Vaccine is, and has been since at least 1999, far less than 95 percent effective.
    -Merck designed a testing methodology that evaluated its vaccine against a less virulent strain of the mumps virus. After the results failed to yield Merck’s desired efficacy, Merck abandoned the methodology and concealed the study’s findings. The lawsuit states Merck committed fraud by:
    …incorporating the use of animal antibodies to artificially inflate the results…
    …destroying evidence of the falsified data and then lying to an FDA investigator…
    …threatened a virologist in Merck’s vaccine division with jail if he reported the fraud to the FDA…
    …the ultimate victims here are the millions of children who every year are being injected with a mumps vaccine that is not providing them with an adequate level of protection. And while this is a disease that, according to the Centers for Disease Control (‘CDC’), was supposed to be eradicated by now, the failure in Merck’s vaccine has allowed this disease to linger, with significant outbreaks continuing to occur.

    UNITED STATES DISTRICT COURT THE EASTERN DISTRICT OF PENNSYLVANIA United States of America ex rel., Stephen A Krahling and Joan A Wlochowski, AMENDED
    ACT FILED Merck & . Defendant http://sanevax(dot)org/wp-content/uploads/2012/06/Merck-mumps-suit.pdf
    -COURTHOUSE NEWS SERVICE: Class Says Merck Lied About Mumps Vaccine By REUBEN KRAMER http://www.courthousenews(dot)com/2012/06/27/47851.htm

    -Vaccine Whistleblowers File to Compel Merck to Respond to Federal Lawsuit: http://healthimpactnews(dot)com/2015/vaccine-whistleblowers-file-to-compel-merk-to-respond-to-federal-lawsuit/
    Reuters, Wall Street Journal, report on Merck’s mumps fraud case
    Judge: Lawsuit Against Merck’s MMR Vaccine Fraud to Continue
    -Memorandum issued by Judge explaining his ruling. http://www.rescuepost(dot)com/files/59-opinion.pdf
    Chatom Primary Care sues Merck for Sherman Act monopolization, breach of warranty, violation of consumer protection laws. The lawsuit record is available here: http://www.naturalnews(dot)com/gallery/documents/Chatom-Lawsuit-Merck-Mumps.pdf.
    Chatom Primary Care also alleges that the fraudulent Merck vaccine contributed to the 2006 mumps outbreak in the Midwest, and a 2009 outbreak elsewhere. It says, “there has remained a significant risk of aresurgence of mumps outbreaks…”

Leave a Reply

Your email address will not be published. Required fields are marked *


A collaboration between The Englert Theatre and FilmScene


Help us build the greatest small city for the arts in America—right here in Iowa City. Learn more »

Donate Today

Strengthen • Grow • Evolve is a collaborative campaign led by two Iowa City-based arts nonprofits, The Englert Theatre and FilmScene that seeks a major reinvestment to strengthen the arts through modern and historic venues, innovative programming, and new models of collaboration.

For 18 years...

Little Village has been telling the truth and changing our little corner of the world.

If you can, help us head into the next 18 years even stronger with a one-time or monthly contribution of $18, or any amount you choose.

Little Village
2019 Give Guide

Get to know some of the nonprofits helping to make the CRANDIC a better place to live.